Wegovy vs. Zepbound vs. Compounded GLP-1: Patient Outcome Data

Branded Semaglutide Performance

Wegovy is the brand name for semaglutide approved for chronic weight management. Clinical trials showed significant body weight reduction over 68 weeks. Most patients achieve a 15 percent weight loss. However, supply chain issues often disrupt treatment cycles for clinic patients.

• Consistent 14.9 percent mean weight loss in STEP trials
• Once-weekly subcutaneous injection protocol
• Common side effects include nausea and constipation
• High manufacturer hardware reliability

Zepbound and Dual Agonism

Zepbound uses tirzepatide to target both GLP-1 and GIP receptors. This dual-action approach often leads to higher weight loss percentages than semaglutide alone. Clinical data suggests a 20 percent or higher weight reduction in many patients.

• Superior weight loss compared to semaglutide in SURMOUNT trials
• Inhibits gastric emptying and improves insulin sensitivity
• Higher cost floor compared to single-agonist drugs
• Strict titration schedule required for patient tolerance

Outcomes with Compounded Alternatives

Compounded semaglutide and tirzepatide offer comparable clinical outcomes when sourced from reputable 503A or 503B pharmacies. The primary advantage for clinics is the ability to customize dosages. This flexibility helps manage side effects and plateaus more effectively than fixed-dose branded pens.

• Custom titration prevents severe gastrointestinal distress
• Identical active pharmaceutical ingredients (API)
• Elimination of pharmacy-level backorders for patients
• Improved patient retention due to cost accessibility

Addressing Bioavailability and Purity

Patient outcomes depend on the purity of the molecule. Our platform ensures all peptides are tested for identity and potency. Branded drugs offer standardized delivery, but compounded options allow clinicians to add B-vitamins to mitigate fatigue. This often leads to better patient satisfaction scores.

• Third-party testing for every batch
• pH balancing for reduced injection site pain
• Options for additives like Cyanocobalamin
• Clear certificates of analysis for medical directors

Long Term Adherence Rates

Weight loss success requires months of consistency. High prices for branded Wegovy and Zepbound lead to high dropout rates. Patients who cannot afford the monthly retail price often stop treatment before hitting their goal. Compounded options allow for a more sustainable business model and better health results.